Array of Clinical Trials in Biosimilars

A clinical trial is an examination study that tests another restorative treatment or another method for utilizing a current treatment to check whether it will be a superior approach to counteract and screen for analyse or treat a disease1. For any new medication to enter in clinical trial, it must pass preclinical studies. Preclinical studies  of Biosimilars include in vitro (i.e. test-tube or Laboratory) studies and trials on creature populaces. Extensive variety of measurements of the study medication is given to creature subjects or to an in-vitro substrate with a specific end goal to acquire preparatory adequacy, poisonous quality and pharmacokinetic data and includes Preclinical Studies in Phase I-IV.

The proliferation of generic drugs  largely has been hailed as an economic and consumer triumph.  In 2013, more than 85% of all prescriptions in the United States were filled by generic drugs.  Under FDA regulations, generic drugs must be chemically equivalent, have the same active ingredients, and be bioequivalent to their branded counterparts.  However, the requirements for safety labelling on branded and generic drugs differ in important ways. Most notably, while a branded drug manufacturer is responsible for the accuracy and adequacy of its drug label, a generic drug company is responsible for ensuring that its warning label is the same as the label of the brand-name reference listed drug (RLD

  • Non-Clinical Studies in biosimilars development
  • Biosimilars development and impact on clinical practice
  • Optimising biosimilar clinical trial design
  • Preclinical and Clinical Development

Related Conference of Array of Clinical Trials in Biosimilars

July 03-04, 2017

4th Annual Congress on Drug Discovery & Designing

Bangkok, Thailand
August 10-12, 2017

8th Asian Biologics and Biosimilars Congress

Beijing, China
September 20-21, 2017

10th Pharmacovigilance Congress

Charlotte, North Carolina, USA
September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 02-04, 2017

World Congress on Antibiotics: R&D, Market

Atlanta, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria

Array of Clinical Trials in Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in